FANCD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.821400E-01
Normal-vs-Stage2
5.786800E-01
Normal-vs-Stage3
3.771200E-01
Normal-vs-Stage4
4.793400E-01
Stage1-vs-Stage2
2.901600E-01
Stage1-vs-Stage3
2.026000E-01
Stage1-vs-Stage4
9.791200E-01
Stage2-vs-Stage3
4.881600E-02
Stage2-vs-Stage4
3.717600E-01
Stage3-vs-Stage4
1.518640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.650200E-01
Normal-vs-AfricanAmerican
4.536800E-01
Normal-vs-Asian
5.687600E-01
Caucasian-vs-AfricanAmerican
2.340600E-01
Caucasian-vs-Asian
9.831000E-01
AfricanAmerican-vs-Asian
1.827960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.524400E-01
Normal-vs-Female
5.661800E-01
Male-vs-Female
7.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.980600E-01
Normal-vs-Age(41-60Yrs)
5.635400E-01
Normal-vs-Age(61-80Yrs)
5.540600E-01
Normal-vs-Age(81-100Yrs)
5.895400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.547000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.239000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.994000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.203200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.639800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.079000E-01
Normal-vs-Daily Drinker
5.354000E-01
Normal-vs-Weekly Drinker
5.949800E-01
Normal-vs-Occasional Drinker
5.492600E-01
Normal-vs-Social Drinker
5.624600E-01
Non Drinker-vs-Daily Drinker
3.209000E-01
Non Drinker-vs-Weekly Drinker
8.844400E-01
Non Drinker-vs-Occasional Drinker
5.136400E-01
Non Drinker-vs-Social Drinker
5.635000E-01
Daily Drinker-vs-Weekly Drinker
5.895200E-01
Daily Drinker-vs-Occasional Drinker
8.551000E-01
Daily Drinker-vs-Social Drinker
6.622000E-01
Weekly Drinker-vs-Occasional Drinker
6.931000E-01
Weekly Drinker-vs-Social Drinker
7.897400E-01
Occasional Drinker-vs-Social Drinker
8.564200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.619800E-01
Normal-vs-Grade 2
7.300000E-01
Normal-vs-Grade 3
7.759600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.235550E-01
Grade 1-vs-Grade 3
1.850160E-02
Grade 1-vs-Grade 4
6.619800E-01
Grade 2-vs-Grade 3
1.334450E-01
Grade 2-vs-Grade 4
7.300000E-01
Grade 3-vs-Grade 4
7.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.625200E-01
Normal-vs-NonDiabetic
5.543200E-01
Diabetic-vs-NonDiabetic
8.702400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.418400E-01
Normal-vs-NoPancreatitis
5.503200E-01
Pancreatitis-vs-NoPancreatitis
2.442800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.880200E-01
Normal-vs-N1
5.557000E-01
N0-vs-N1
4.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.278800E-01
Normal-vs-TP53-NonMutant
5.532400E-01
TP53-Mutant-vs-TP53-NonMutant
1.900780E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
